Crinetics Pharmaceuticals Inc buy Citigroup Inc.
Start price
14.11.24
/
50%
€57.00
Target price
14.11.25
€70.14
Performance (%)
-36.14%
End price
15.11.25
€36.40
Summary
This prediction ended on 15.11.25 with a price of €36.40. The BUY prediction by Citigroup_Inc_ for Crinetics Pharmaceuticals Inc performed very badly with a performance of -36.14%. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Crinetics Pharmaceuticals Inc | 3.145% | 3.145% | 3.145% |
| iShares Core DAX® | -2.117% | -7.974% | -1.733% |
| iShares Nasdaq 100 | -1.323% | -0.066% | 16.602% |
| iShares Nikkei 225® | -0.324% | -6.382% | 25.629% |
| iShares S&P 500 | -1.568% | -1.965% | 10.831% |
Comments by Citigroup_Inc_ for this prediction
In the thread Crinetics Pharmaceuticals Inc diskutieren
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) had its price target raised by analysts at Citigroup Inc. from $70.00 to $74.00. They now have a "buy" rating on the stock.
Ratings data for CRNX provided by MarketBeat
In the thread Trading Crinetics Pharmaceuticals Inc
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten